Tezomib 2mg Injection

About

Bortezomib is a potent and reversible proteasome inhibitor, a class of antineoplastic agents used primarily in the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting the 26S proteasome, a multi-enzyme complex responsible for degrading ubiquitinated proteins, including those involved in cell cycle regulation, apoptosis, and transcription. This inhibition leads to an accumulation of misfolded proteins, disruption of cellular homeostasis, and ultimately, induction of apoptosis in cancer cells. Bortezomib is administered intravenously or subcutaneously and has demonstrated significant efficacy in both newly diagnosed and relapsed/refractory settings.

Uses

• Treatment of multiple myeloma.
• Management of mantle cell lymphoma.
• Used in relapsed or refractory multiple myeloma.
• Part of combination therapy for newly diagnosed multiple myeloma.

Directions For Use

This medication is administered by a healthcare professional via intravenous or subcutaneous injection.

Benefits

• Highly effective in treating multiple myeloma.
• Significant impact on mantle cell lymphoma.
• Improves progression-free and overall survival.
• Can be used as monotherapy or in combination regimens.
• Well-established efficacy in various patient populations.
• Subcutaneous administration offers convenience and reduced neuropathy risk.

Side Effects

• Peripheral neuropathy
• Thrombocytopenia (low platelet count)
• Neutropenia (low white blood cell count)
• Fatigue
• Nausea
• Diarrhea
• Constipation
• Fever
• Headache
• Rash
• Muscle weakness
• Hypotension (low blood pressure)
• Herpes zoster reactivation

Safety Measures

• Alcohol - No specific interaction, but general caution is advised due to potential for fatigue or dizziness.
• Pregnancy - Not recommended during pregnancy due to potential for fetal harm. Women of childbearing potential should use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as the drug may pass into breast milk and cause serious adverse effects in the infant.
• Liver - Use with caution in patients with moderate to severe liver impairment. Dose adjustments may be necessary based on liver function.
• Kidney - Use with caution in patients with kidney impairment. No specific dose adjustment is typically required for mild to moderate impairment.
• Lung - Monitor for acute diffuse infiltrative pulmonary disease, which can be a serious but rare adverse event.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.